US 12180277
LILRB4-binding antibody and methods of use thereof
granted A61KA61K2039/505A61K39/00
Quick answer
US patent 12180277 (LILRB4-binding antibody and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K39/00, A61K45/06, A61P